Which hedge funds own NBIX? NEUROCRINE BIOSCIENCES INC, Q2 2026 13F holders
Healthcare · Open on the interactive board
7 of the hedge funds tracked by WhaleCreep disclosed a position in NBIX (NEUROCRINE BIOSCIENCES INC) in their Q2 2026 13F filings, worth $479.8m in total. The largest holder by portfolio weight is Renaissance Technologies LLC at 0.5% of its book. 1 exited: Brevan Howard Capital Management.
7tracked managers holding
0opened this quarter
1exited this quarter
Which hedge funds hold NBIX? Current holders by portfolio weight
| Manager | As of | Weight of book | Value | Shares | Δ shares | Action |
|---|---|---|---|---|---|---|
| Renaissance Technologies LLC | Q2 2026 | 0.5% | $393.7m | 2,335,897 | -3% | reduced |
| Bridgewater Associates | Q2 2026 | 0.1% | $34.7m | 205,677 | 39% | added |
| Marshall Wace | Q2 2026 | 0.0% | $45.6m | 270,754 | -47% | reduced |
| Woodline Partners | Q2 2026 | 0.0% | $915.0k | 5,429 | 40% | added |
| Millennium Management | Q2 2026 | 0.0% | $2.0m | 11,585 | -99% | reduced |
| Citadel Advisors | Q2 2026 | 0.0% | $2.0m | 11,863 | -80% | reduced |
| D. E. Shaw & Co | Q2 2026 | 0.0% | $943.6k | 5,599 | -94% | reduced |
Exited since the previous quarter
| Manager | Prior weight | Prior value |
|---|---|---|
| Brevan Howard Capital Management | 0.1% | $1.4m |
How has hedge fund ownership of NBIX changed?
| Quarter | Managers holding | Combined value |
|---|---|---|
| Q2 2026 | 7 | $479.8m |
| Q1 2026 | 8 | $590.9m |
| Q4 2025 | 4 | $351.8m |
| Q3 2025 | 4 | $347.2m |
| Q2 2025 | 5 | $307.7m |
| Q1 2025 | 6 | $337.3m |
| Q4 2024 | 5 | $442.7m |
| Q3 2024 | 5 | $382.6m |
| Q2 2024 | 9 | $481.8m |
| Q1 2024 | 7 | $544.8m |
| Q4 2023 | 8 | $582.9m |
| Q3 2023 | 9 | $650.8m |
| Q2 2023 | 5 | $342.1m |
| Q1 2023 | 5 | $326.5m |
| Q4 2022 | 6 | $448.5m |
| Q3 2022 | 3 | $350.6m |
Counts every tracked manager that disclosed NBIX in that quarter's filing, including managers that have since stopped filing.